Genmab — Januar 2019
-
Der må være al den kritik man har lyst til her. Undtaget er dog personlig rettet kritik. Den sletter jeg.
-
Det er heldigvis meget sjældent nødvendigt.
-
Godt vi har Helge som Big Brother..:-)
-
Debatten om emnet slutter her.
-
@peter12. Tak. Hvis jeg ellers læser det rigtigt, så var der 4,4% den 28/12-2018.
-
Jeps.
-
the completion date for the MAIA trial is extended for another 1 1/2 years; can we conclude anything from that? that PFS keeps improving? or is that too simple… https://clinicaltrials.gov/ct2/history/NCT02252172?A=46&B=47&C=merged
-
Mere dara hype fra Dr Raje Massacusetts General Hospital ca 10:30 https://youtu.be/p_Xd9JwEPEw
-
Daratumumab/VRd Regimen Has Practice-Changing Potential in Myeloma
https://www.onclive.com/web-exclusives/daratumumabvrd-regimen-has-practicechanging-potential-in-myeloma -
og god morgenHello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind